Login / Signup

A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer.

Thoudam Debraj SinghYoung Shin SongJina KimJungwook ChinHyun Dong JiJae-Eon LeeSang Bong LeeHeeseok YoonJi Hoon YuSang Kyoon KimGhil Suk YoonHayoung HwangHo Won LeeJi Min OhSang-Woo LeeJaetae LeeHueng-Sik ChoiSoon-Young NaWon-Il ChoiYoung Joo ParkYoung A KimIn-Kyu LeeSung Jin ChoYong Hyun Jeon
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
DN200434 shows potential clinical applicability for diagnosis and treatment of ATC or other poorly differentiated thyroid cancers.
Keyphrases
  • human health
  • drug induced